Table 2 Characteristics of the cohort comprising sJIA and “suspected” sJIA cohort
Characteristics | sJIA (ie. fulfilling ILAR criteria) | “suspected” sJIA | Total cohort |
|---|---|---|---|
n = 18 | n =13 | n = 31 | |
Mean age (years) | 11.9 | 6.9** | 9.8 |
Male:Female | 13:5 | 7:6NS | 20:11 |
Mean duration of symptoms at time of presentation (days) | 109.1 | 51.8NS | 85.1 |
Number of patients who received pre treatment with steroids | 8(44.4%) | 2(15.4%)NS | 10 |
Mean daily dose of steroids (mg/kg/day)# | 0.96 | 2.47NS | 1.3 |
Mean number of days that the patients had received steroids | 8.13 | 7.5NS | 8 |
Number of patients who developed MAS on follow up | 1 | 6* | 7 |
Average number of joints | 9 | 0* | 5.2 |
Mean ESR(mm/hr) | 62.2 | 43.8** | 54.5 |
Mean CRP (mg/L) | 130.5 | 116.2 NS | 124.2 |
Mean Hemoglobin (gm/dL) | 10.9 | 10.2 NS | 10.6 |
Mean WBC (cells x 109/L) | 15.2 | 20.7 NS | 17.5 |
Mean platelet count (cells x 109/L) | 337.6 | 468.4 NS | 413.6 |
Mean ALT (U/L) | 62.4 | 107.9 NS | 81.5 |
Mean AST (U/L) | 55.5 | 41.3 NS | 49.5 |